Unknown

Dataset Information

Integrating pharmacogenomics and cheminformatics with diverse disease phenotypes for cell type-guided drug discovery.


ABSTRACT:

Background

Large-scale pharmacogenomic resources, such as the Connectivity Map (CMap), have greatly assisted computational drug discovery. However, despite their widespread use, CMap-based methods have thus far been agnostic to the biological activity of drugs as well as to the genomic effects of drugs in multiple disease contexts. Here, we present a network-based statistical approach, Pathopticon, that uses CMap to build cell type-specific gene-drug perturbation networks and integrates these networks with cheminformatic data and diverse disease phenotypes to prioritize drugs in a cell type-dependent manner.

Methods

We build cell type-specific gene-drug perturbation networks from CMap data using a statistical procedure we call Quantile-based Instance Z-score Consensus (QUIZ-

SUBMITTER: Halu A 

PROVIDER: S-EPMC11744892 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature